Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,689Revenue $M688Net Margin (%)2.3Z-Score1.6
Enterprise Value $M1,561EPS $0.3Operating Margin %1.9F-Score3
P/E(ttm))0Cash Flow Per Share $1.5Pre-tax Margin (%)2.4Higher ROA y-yN
Price/Book1.710-y EBITDA Growth Rate %0Quick Ratio2.9Cash flow > EarningsY
Price/Sales2.45-y EBITDA Growth Rate %0Current Ratio3.4Lower Leverage y-yY
Price/Cash Flow14.3y-y EBITDA Growth Rate %-50.3ROA % (ttm)0.9Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)1.7Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M65.0ROI % (ttm)3.7Gross Margin Increase y-yN

Gurus Latest Trades with MDCO

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
MDCOJoel Greenblatt 2014-06-30 Buy 0.07%$24.02 - $29.57
($26.67)
$ 25.93-3%New holding, 194954 sh.194,954
MDCOGeorge Soros 2014-06-30 Buy 0.02%$24.02 - $29.57
($26.67)
$ 25.93-3%New holding, 75000 sh.75,000
MDCOJohn Hussman 2014-06-30 Sold Out -0.14%$24.02 - $29.57
($26.67)
$ 25.93-3%Sold Out0
MDCOJohn Hussman 2014-03-31 Reduce-0.1%$27.9 - $40.39
($33.42)
$ 25.93-22%Reduce -35.58%67,000
MDCOGeorge Soros 2014-03-31 Sold Out -0.02%$27.9 - $40.39
($33.35)
$ 25.93-22%Sold Out0
MDCOJoel Greenblatt 2014-03-31 Sold Out -0.01%$27.9 - $40.39
($33.35)
$ 25.93-22%Sold Out0
MDCOJoel Greenblatt 2013-12-31 Buy 0.01%$31.48 - $38.91
($35.74)
$ 25.93-27%New holding, 13990 sh.13,990
MDCOGeorge Soros 2013-12-31 Reduce-0.07%$31.48 - $38.91
($35.74)
$ 25.93-27%Reduce -80%50,000
MDCOVanguard Health Care Fund 2013-09-30 Add0.33%$29.68 - $34.54
($31.83)
$ 25.93-18%Add 219.22%4,250,415
MDCOGeorge Soros 2013-09-30 Add0.04%$29.68 - $34.54
($31.83)
$ 25.93-18%Add 66.67%250,000
MDCOJohn Hussman 2013-09-30 Reduce-0.57%$29.68 - $34.54
($31.83)
$ 25.93-18%Reduce -79.73%104,000
MDCOVanguard Health Care Fund 2013-06-30 Add0.1%$30.76 - $37.1
($33.46)
$ 25.93-22%Add 181.56%1,331,500
MDCOGeorge Soros 2013-06-30 Add0.02%$30.76 - $37.1
($33.46)
$ 25.93-22%Add 57.89%150,000
MDCOJohn Hussman 2013-06-30 Reduce-0.22%$30.76 - $37.1
($33.46)
$ 25.93-22%Reduce -26.29%513,000
MDCOVanguard Health Care Fund 2013-03-31 Buy 0.06%$23.97 - $33.41
($30.53)
$ 25.93-15%New holding, 472900 sh.472,900
MDCOGeorge Soros 2013-03-31 Buy 0.04%$23.97 - $33.41
($30.53)
$ 25.93-15%New holding, 95000 sh.95,000
MDCOJohn Burbank 2013-03-31 Sold Out -0.09%$23.97 - $33.41
($30.53)
$ 25.93-15%Sold Out0
MDCOJohn Burbank 2012-12-31 Buy 0.09%$20.34 - $26.64
($22.78)
$ 25.9314%New holding, 100000 sh.100,000
MDCOJohn Hussman 2012-09-30 Buy 0.38%$22.88 - $26.68
($25.03)
$ 25.934%New holding, 615000 sh.615,000
MDCOJoel Greenblatt 2012-09-30 Sold Out -0.03%$22.88 - $26.68
($25.03)
$ 25.934%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MDCO is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
MDCO George Soros 2014-06-3075,0000.120.02New Buy
MDCO Joel Greenblatt 2014-06-30194,9540.30.07New Buy
MDCO Vanguard Health Care Fund 2014-06-304,700,0587.230.36
MDCO John Hussman 2014-06-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


MDCO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
O'Connor William BernardSr VP & Chief Acct. Officer 2014-03-03Sell2,968$30.31-14.45view
MEANWELL CLIVEChairman & CEO 2014-02-03Sell10,000$34.29-24.38view
Antinori Paul MichaelSr. VP & General Counsel 2014-01-21Sell37,883$38.02-31.8view
O'Connor William BernardSr VP & Chief Acct. Officer 2014-01-15Sell4,427$39.15-33.77view
O'Connor William BernardSr VP & Chief Acct. Officer 2014-01-10Sell72,384$40-35.18view
MEANWELL CLIVEChairman & CEO 2014-01-07Sell27,929$38.13-32view
MEANWELL CLIVEChairman & CEO 2014-01-03Sell57,516$38.16-32.05view
Antinori Paul MichaelSr. VP & General Counsel 2013-12-13Sell19,600$36.96-29.84view
CROUSE WILLIAMDirector 2013-12-09Sell12,500$38-31.76view
SBLENDORIO GLENNPresident & CFO 2013-12-05Sell8,516$38.5-32.65view

Press Releases about MDCO :

Quarterly/Annual Reports about MDCO:

News about MDCO:

Articles On GuruFocus.com
Chuck Royce Buys Stifel Financial, Tidewater, Alamos, Sells Kennametal, Gardner Denver, Gartner Apr 25 2013 
Weekly CFO Sells Highlight: BK, MDCO, EBAY, MS, PHMD Jan 27 2013 
Weekly CFO Sells Highlight: MDCO, SIG, VCI, PHMD, SNPS Jan 21 2013 
George Soros' Top Buys in the Last Quarter Dec 23 2011 
George Soros Buys Amazon.com Inc., Motorola Solutions, Sandisk, Sells Ralph Lauren, Dendreon, Lawson Nov 15 2011 
Medicines Company (MDCO) Chairman & CEO Clive Meanwell sells 100,000 Shares Mar 01 2011 
Medicines Company Reports Operating Results (10-Q) Nov 09 2010 
Medicines Company Reports Operating Results (10-Q) May 10 2010 
Medicines Company (MDCO) Chairman & CEO Clive Meanwell sells 181,500 Shares May 04 2010 
Medicines Company Reports Operating Results (10-Q) Nov 09 2009 

More From Other Websites
MEDICINES CO /DE Files SEC form 8-K, Other Events, Financial Statements and Exhibits Aug 11 2014
MEDICINES CO /DE Financials Aug 09 2014
The Medicines Company's Orbactiv Approved on Solid SOLO Data Aug 07 2014
[$$] The Medicines Co. Offers Investors 25% Upside Aug 07 2014
Is Durata's Antibiotic Overpriced? A Twitter Conversation Aug 07 2014
The Medicines Company and Alnylam Pharmaceuticals to Host RNAi Roundtable Webcast “ALN-PCSsc for... Aug 07 2014
The Medicines Company and Alnylam Pharmaceuticals to Host RNAi Roundtable Webcast “ALN-PCSsc for... Aug 07 2014
Medicines Co's ORBACTIVT FDA Approval Call scheduled for 8:00 am ET today Aug 07 2014
FDA Approves The Medicines Company's ORBACTIV™ (oritavancin) for Use in Acute Bacterial Skin and... Aug 06 2014
FDA Approves The Medicines Company's ORBACTIV™ (oritavancin) for Use in Acute Bacterial Skin and... Aug 06 2014
The R&D elite: America's most innovative companies Aug 06 2014
MEDICINES CO /DE Files SEC form 10-Q, Quarterly Report Aug 04 2014
The Medicines Company to Host Infectious Disease Care Investor and Analyst Meeting on September 24,... Aug 04 2014
The Medicines Company to Host Infectious Disease Care Investor and Analyst Meeting on September 24,... Aug 04 2014
The Medicines Co.'s (MDCO) Q2 Earnings Decline Y/Y Jul 24 2014
Medicines (MDCO) is Oversold: Can It Recover? Jul 24 2014
The Medicines Company Reports Second Quarter and First Half 2014 Results Jul 23 2014
Medicines Co Earnings Call scheduled for 8:30 am ET today Jul 23 2014
MEDICINES CO /DE Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jul 23 2014
Q2 2014 The Medicines Company Earnings Release - Before Market Open Jul 23 2014

Add Notes, Comments or Ask Questions

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide